Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
Perez-Molina, José A, Rubio, Rafael, Rivero, Antonio, Pasquau, Juan, Suárez-Lozano, Ignacio, Riera, Melcior, Estébanez, Miriam, Santos, Jesús, Sanz-Moreno, José, Troya, Jesús, Mariño, Ana, Antela, AntVolume:
15
Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/s1473-3099(15)00097-3
Date:
July, 2015
File:
PDF, 301 KB
english, 2015